(Reuters) – Pfizer Inc is in advanced talks to buy drugmaker Global Blood Therapeutics for about $5 billion, the Wall Street Journal reported on Friday, citing people familiar with the matter.

(Reporting by Amruta Khandekar; Editing by Aditya Soni)